Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of cancer involving mutated KRAS or BRAF genes

Treatment of cancer involving mutated KRAS or BRAF genes

US Patent 8932588 · Granted Jan 13, 2015

Estimated economic value: $226,618,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polynucleotides encoding antibodies that specifically bind to human IL-152025
Antibodies that specifically bind to TL1a and methods of treating gastrointestin2025
Anti-PAR-2 antibodies and methods of use thereof2025
Compositions and methods for anti-PACAP antibodies2025
Anti-pd-1 antibody-attenuated IL-2 immunoconjugates and uses thereof2025
Antibodies that specifically bind to TL1A and methods of treating gastrointestin2024
Anti-CXCR2 antibodies and uses thereof2024
Anti-PAR-2 antibodies and methods of use thereof2023
Anti-CXCR2 antibodies and uses thereof2022
Interferon alpha 2B variants2022
Antibodies that specifically bind to human IL-15 and uses thereof2022
Combination of lenalidomide and polypeptide construct, and uses thereof2022